Evidence map›Paper›PMID 19442309›Full record

ArticleCritical care (London, England)2009

Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis.

Eduardo Ferat-Osorio, Isabel Wong-Baeza, Noemí Esquivel-Callejas, Silvia Figueroa-Figueroa, Andrés Duarte-Rojo, Gilberto Guzmán-Valdivia-Gómez, Heriberto Rodea-Rosas, Rubén Torres-González, Patricio Sánchez-Fernández, Lourdes Arriaga-Pizano and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Critical care (London, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Circulating monocytes in acute pancreatitis.Frontiers in immunology · 2022
    Review
  9. Article
  10. Serum levels of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in predicting the severity of acute pancreatitis.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2019
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Eduardo Ferat-OsorioMedical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre Siglo XXI, Mexican Institute for Social Security, Mexico City, Mexico. eduardoferat@prodigy.net.mx
Isabel Wong-Baeza
Noemí Esquivel-Callejas
Silvia Figueroa-Figueroa
Andrés Duarte-Rojo
Gilberto Guzmán-Valdivia-Gómez
Heriberto Rodea-Rosas
Rubén Torres-González
Patricio Sánchez-Fernández
Lourdes Arriaga-Pizano
Constantino López-Macías
Guillermo Robles-Díaz
Armando Isibasi
Mexican Social Security Institute · MXHospital General de México · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcute pancreatitis (AP) is usually a mild and self-limiting disease, but some patients develop a severe form that is associated with high mortality. In AP, local inflammation is followed first by the systemic inflammatory response syndrome and then by the compensatory anti-inflammatory response syndrome, which is defined by low human leukocyte antigen (HLA)-DR expression on monocytes, increased concentration of the anti-inflammatory cytokine IL-10, and decreased monocyte function. Our aim was to measure the expression of triggering receptor expressed on myeloid cells (TREM)-1 (a proposed marker of infection or inflammation) and HLA-DR on monocytes, and the serum concentrations of IL-6 (a proinflammatory cytokine) and IL-10 in patients with AP to determine whether these markers can identify patients at high risk of developing severe AP or infection.

methodsFifty healthy volunteers, 18 patients with mild AP, and 11 patients with severe AP were included in this study. Samples were taken at admission and one and three days later. TREM-1 and HLA-DR expression was evaluated by flow cytometry, and soluble TREM-1, IL-6 and IL-10 concentrations were measured by ELISA.

resultsTREM-1 expression was higher in patients with AP than in healthy volunteers, but there was no difference between patients with mild and severe AP. TREM-1 expression was not associated with mortality or with the presence of infection. Soluble TREM-1 concentration in serum was higher in non-survivors than in survivors. HLA-DR expression was lower and IL-6 concentration higher in patients with severe AP and in infected patients.

conclusionsIncreased TREM-1 expression was associated with the presence of inflammation but not infection in AP. In patients with AP, low HLA-DR expression and high IL-6 concentration could predict severity and infection in samples taken shortly after admission.

Indexed as

AdolescentAdultAgedBiomarkersCase-Control StudiesFemaleHLA-DR AntigensHumansInfectionsInterleukin-10Interleukin-6MaleMembrane GlycoproteinsMiddle AgedMonocytesPancreatitisBiomarkersHLA-DR AntigensInterleukin-10Interleukin-6Membrane GlycoproteinsReceptors, ImmunologicTREM1 protein, humanTriggering Receptor Expressed on Myeloid Cells-1

Identifiers

PMID19442309
PMCPMC2717428
OpenAlexW2137862508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.